EUVIMEDEUVIMED entdecken
Crossref

Frailty in end-stage kidney disease: A multidimensional approach to risk stratification and personalized care

Tariq Ahmed Zayan, Heba Abouelyazied Khafagy

World Advances in Renal Medicine · 2026

DOI: 10.25259/warm_16_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Advances in Renal Medicine, 2026. Verfasst von Tariq Ahmed Zayan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frailty is increasingly recognized as a critical determinant of outcomes in end-stage kidney disease (ESKD), affecting up to 70% of dialysis patients and 20% of kidney transplant candidates.

Objective

This review synthesizes current evidence on frailty in ESKD, focusing on definition, assessment, outcomes, modality differences, interventions, and implementation strategies. Key Findings: Frailty in ESKD results from complex interactions between uremia-related factors, comorbidities, and aging processes. While the Fried Frailty Phenotype remains the most widely used assessment tool, the clinical frailty scale (CFS) offers practical advantages in clinical settings. Frailty independently predicts mortality (2.6-fold increased risk), hospitalization, falls, and post-transplant complications. Comparative studies suggest that while frailty prevalence is similar between hemodialysis and peritoneal dialysis patients (approximately 40–43%), some frail patients still derive survival benefit from kidney transplantation despite increased perioperative risks. Multimodal interventions combining nutritional support, exercise training, and cognitive rehabilitation show promise in attenuating frailty progression.

Conclusion

Incorporating frailty assessment into routine nephrology care enables risk stratification and personalized management strategies. The CFS represents a practical tool for resource-limited settings.

Zitieren

APA

Zayan, T. A., & Khafagy, H. A. (2026). Frailty in end-stage kidney disease: A multidimensional approach to risk stratification and personalized care. World Advances in Renal Medicine. https://doi.org/10.25259/warm_16_2025

Vancouver

Zayan TA, Khafagy HA. Frailty in end-stage kidney disease: A multidimensional approach to risk stratification and personalized care. World Advances in Renal Medicine. 2026. doi:10.25259/warm_16_2025

BibTeX
@article{Zayan2026,
  author = {Zayan, Tariq Ahmed and Khafagy, Heba Abouelyazied},
  title = {Frailty in end-stage kidney disease: A multidimensional approach to risk stratification and personalized care},
  journal = {World Advances in Renal Medicine},
  year = {2026},
  doi = {10.25259/warm_16_2025}
}
Kostenlos starten →